 Garfield Heights, Ohio -- Medical device company AxioMed Spine has received $5 million in fourth round venture capital investment.
AxioMed developed products for "restoring native function to patients with degenerative spine disease."
Investors in the financing round were not disclosed, nor was how the company intends to use the funding proceeds.
AxioMed is backed by a syndicate of venture capital and private equity investors. |